Core Scientific

CORZ Data Centers & REITs Risk Unknown

Core Scientific carries $2.1B in long-term debt, with $1.1B in scheduled principal maturities. Insufficient data is available to calculate a reliable risk score for CORZ.

Maturity Schedule

As of 2026-03-31 (latest SEC filing with maturity data). Debt actions taken after this date will only appear once SEC processes the relevant XBRL filing.
Year 1 $0 Year 2 $0 Year 3 $0 Year 4 $0 Year 5 $0 Beyond 5 $1.1B
Period Amount Due % of Total
Year 1 (0-12 months) N/A N/A
Year 2 (12-24 months) N/A N/A
Year 3 (24-36 months) N/A N/A
Year 4 (36-48 months) N/A N/A
Year 5 (48-60 months) N/A N/A
Beyond 5 Years $1.1B 100.0%
Total Scheduled Maturities $1.1B 100.0%
Why don't these totals match? Total scheduled maturities ($1.1B) falls short of balance-sheet long-term debt ($2.1B) by about 48%. The two figures come from different disclosures: the maturity schedule aggregates gross principal repayments from the debt footnote — typically including the current portion of long-term debt and sometimes finance leases — while balance-sheet long-term debt is a carrying value that excludes the current portion and is net of unamortized discounts, premiums, and issuance costs. They can also come from filings with different period-end dates (2026-03-31 vs 2026-03-31). Both numbers are shown exactly as reported to the SEC.

Key Metrics

Total Long-Term Debt
$2.1B
Near-Term (12mo)
N/A
Interest Coverage
N/A
Debt/Equity
N/A
Cash Coverage
1.01x
Operating Income
-$246M

How This Score Was Computed

Only 1 of 5 score components could be calculated — not enough for a reliable composite. The score is withheld rather than published on thin data.

Component Value Sub-Score Weight Used
Near-Term Maturity Concentration
No Year-1 maturity bucket was reported in recent filings.
N/A not scored
Interest Coverage Ratio
Interest expense was not reported in the latest 10-K.
N/A not scored
Debt-to-Equity Ratio
Stockholders' equity is negative (-$1.3B); a debt-to-equity ratio is not meaningful against negative equity.
N/A not scored
Cash Coverage of Near-Term Debt
Show calculation
Cash & equivalents / Debt due within 12 months
Cash & equivalents: $1.0B
Near-term debt (balance-sheet DebtCurrent): $994M
No Year-1 maturity bucket was reported, so balance-sheet short-term debt (DebtCurrent) is used as the near-term obligation. This is why cash coverage can be scored even when the maturity schedule shows Year 1 as N/A.
1.01x 5/10 100%
Cash Runway
Only scored when a company is burning cash. Operating cash flow is positive (or unreported), so runway isn't a constraint.
N/A not scored

"Weight Used" shows each component's share after the weights of unscored components are redistributed. Full thresholds and formulas are on the methodology page.

Recent SEC Filings

Material disclosures from Core Scientific's most recent EDGAR filings. 8-K item labels indicate the type of event reported.

Date Form Details
2026-05-26 8-K Officer / Director Change, Reg FD Disclosure
2026-05-15 8-K Shareholder Vote
2026-05-06 10-Q Quarterly report
2026-05-06 8-K Earnings Results, Reg FD Disclosure
2026-05-06 8-K Material Agreement, Agreement Terminated, New Debt Obligation, Other Events
2026-05-06 8-K Material Agreement, Reg FD Disclosure
2026-05-05 8-K Officer / Director Change
2026-04-27 8-K Reg FD Disclosure

Related Companies

Data Source: Financial data sourced from SEC EDGAR XBRL filings (10-K annual reports). Fiscal period end: 2026-03-31. Filing date: 2026-05-06. Data last fetched: 2026-07-26. Maturity schedules reflect the company's most recently reported debt repayment obligations. This company does not tag the standard LongTermDebt concept; its debt figure comes from DebtLongtermAndShorttermCombinedAmount. Data quality: Limited.
View SEC EDGAR filings for Core Scientific →